Your session is about to expire
← Back to Search
Study Summary
This trial tests a drug to help relieve nerve pain caused by diabetes.
- Chronic Pain
- Diabetic Neuropathy
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Did the FDA sign off on LY3852710?
"LY3852710's safety is supported by some data, but since this is only a phase 2 trial and there is no evidence for efficacy, it was given a score of 2."
Can people with the condition still sign up for the research project?
"This particular clinical trial is not currently looking for patients, as per the information available on clinicaltrials.gov. This study was first posted on November 14th, 2022 and last updated eleven days ago. There are 717 other trials searching for participants at this time."
In how many different locations is this trial taking place?
"There are 28 clinical trial sites for this medication, with notable locations being Synexus Clinical Research US, Inc. in San Antonio, Texas and Northwest Clinical Research Center in Bellevue, Washington."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger